Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ü¿ÜÃæ°ÝÆļ⼮¼ú ÈÄ ¿ä°ü¼®ÀÇ ¹èÃâ¿¡ ¹ÌÄ¡´Â Tamsulosin°ú NifedipineÀÇ È¿°ú The Effect of Tamsulosin and Nifedipine on Expulsion of Ureteral Stones after Extracorporeal Shock Wave Lithotripsy

´ëÇѺñ´¢±â°úÇÐȸÁö 2008³â 49±Ç 2È£ p.150 ~ 154
ÃÖ³«¿µ, ¾È½ÂÇö, ÇÑÁØÇö, ÀåÀÎÈ£,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ³«¿µ ( Choi Nak-Young ) 
ÇÑÀüÀÇ·áÀç´Ü ÇÑÀϺ´¿ø ºñ´¢±â°úÇб³½Ç

¾È½ÂÇö ( Ahn Seung-Hyun ) 
ÇÑÀüÀÇ·áÀç´Ü ÇÑÀϺ´¿ø ºñ´¢±â°úÇб³½Ç
ÇÑÁØÇö ( Han Jun-Hyun ) 
ÇÑÀüÀÇ·áÀç´Ü ÇÑÀϺ´¿ø ºñ´¢±â°úÇб³½Ç
ÀåÀÎÈ£ ( Chang In-Ho ) 
ÇÑÀüÀÇ·áÀç´Ü ÇÑÀϺ´¿ø ºñ´¢±â°úÇб³½Ç

Abstract


Purpose: We evaluated the effect of tamsulosin and nifedipine on expulsion of ureteral stones after extracorporeal shock wave lithotripsy(ESWL).

Materials and Methods: We evaluated 96 upper or lower ureteral stone patients. All patients received a single session of ESWL with a piezolith- 3000 and received twice-a-day oral treatment of 5mg trospium chloride. The patients were randomly divided into three groups. Group 1 received once a day oral therapy of 0.2mg tamsulosin. Group 2 received once a day oral therapy of 30mg nifedipine. Group 3 was used as the control group. All patients took oral medication for 2 weeks, and then we analyzed the stone expulsion rate, side effects, and mean numbers of emergency room(ER) visits for pain control.

Results: There were no differences in the 3 groups in stone size, location, age, and sex. The total stone expulsion rate was significantly higher in group 1(84.4%) compared with group 3(60.6%)(p=0.032). Patients with lower ureteral stones in group 1 showed a higher expulsion rate(94.1%) than those of group 3(66.7%)(p=0.042). There was no difference in stone expulsion rates between group 2(67.7%) and group 3(60.6%).

Conclusions: These result suggest that adjunctive medical therapy with tamsulosin after an ESWL increased the stone expulsion rate of ureteral stones, especially lower ureteral stones. (Korean J Urol 2008;49:150-154)

Å°¿öµå

Ureteral stones;Extracorporeal shockwave lithotripsy;Tamsulosin;Nifedipine

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS